Skip to content

Glue for Cancer Patients: Suyuan Chen Wins Merck Innovation Cup 2021

Dortmund, 24th August 2021

Suyuan Chen, a doctoral student in the Proteomics working group, won the Merck Innovation Cup 2021 with his "Drug Discovery Technologies" team. Together with six other junior scientists from Israel, Canada, London and Munich, he has worked out a plan on how molecular glue can be created and used even better in cancer treatment in the future.

These small molecules stabilise an interplay between proteins that normally hardly interact. In this way, researchers can "glue" disease-causing proteins to others, which the body then destroys. The doctoral students and postdocs from the disciplines of biochemistry, (structural) biology, chemical proteomics and medicinal and organic chemistry are not allowed to talk publicly about the details of their idea.  Merck has taken up the winning idea in order to pursue it further within the Group. "I am not only happy about the win, but especially that our idea could help advance drug development for cancer therapies," says Chen.

Every year, young researchers can apply for a place at the summer camp and competition of the German science and technology company Merck KGaA. After a two-phase selection process in June 2021, based on CV and project ideas, the applicants were divided into six teams: Oncology, Immuno-Oncology, Immunology, Drug Discovery Technologies, Digitalisation and Pandemic Threat. Over the course of a week at the end of June, the teams not only had to develop their ideas but also prepare and present a complete business plan. For Chen and his teammates, the intensive work in the short time was worth it: the team won first place and 20,000 euros, which they can use at their personal leisure.

Change of perspective & more than just a competition

The "Innovation Cup Summer Camp" - which took place online due to the pandemic - offered participants more than just a competition. In lectures and discussion rounds, experts gave them the technical and economic perspective of a company on new research ideas. In addition, the young scientists learned how to successfully present projects to a corporate management. "It's very exciting to learn how the industry thinks and what the business side looks like for them," Chen concludes. Apart from the change of perspective, he especially liked the opportunity to meet so many like-minded people from all over the world: "In such a diverse group, you learn a lot about teamwork and how to deal with criticism." In the future, the 30-year-old would like to keep in touch with his fellow participants through the alumni group and expand his network to include new international partners and friendships. The winners want to use the prize money to finally meet in person as soon as the pandemic allows.

(Cheyenne Peters)

Suyuan Chen presents his Merck Innovation Cup.

Suyuan Chen presents his Merck Innovation Cup.

© ISAS

Share

Further articles

Four Perspectives on a Shared Discovery

Although CD177⁺ and CD177⁻ neutrophils look identical under the microscope, they are in fact not the same. Four of the authors of “CD177 Deficiency Defines a Stable Subtype of Human Neutrophil Granulocytes with Tumour-Promoting Activity” (Advanced Science) explain how they identified the functional differences between these immune cells and which combined analytical methods made their discovery possible in the first place. This insight into their research demonstrates how interdisciplinary collaboration can reveal previously undiscovered information.

Das Foto zeigt im oberen Teil Porträts von vier Wissenschaftlern. Von links nach rechts: Prof. Dr. Matthias Gunzer, Prof. Dr. Jianxu Chen, Dr. Belal Alshaar, Prof. Dr. Albert Sickmann. Im Teil unter den Porträts sind Mikroskopaufnahmen von CD177-definierten Neutrophilen zu sehen.

3 Questions for... Neele Rottmann

In the lab, Neele Rottmann prepares human and animal samples for mass spectrometry analysis. As part of the HI-FIVE project, she is helping to identify changes at the protein level in heart failure. Why does she spend so much time in the lab working on separations? The technical assistant shares the answer in this interview.

Neele Rottmann is wearing a white lab coat and purple gloves and is operating a mass spectrometry analyser in a laboratory. Next to her is a liquid chromatography system connected to a mass spectrometer via several tubes. There are numerous sample vials on the instrument. As she places a sample into the system, she looks into the camera.

High-tech against Cardiovascular Diseases: 3D Images of Blood Vessels

How do atherosclerotic plaques form in the coronary arteries? At ISAS, researchers are investigating cellular changes in human coronary arteries using techniques such as 3D imaging. During her internship, early-career researcher Leonie Menzel used a light sheet fluorescence microscope to analyse the spatial distribution of individual cells within the tissue. She thereby gained valuable methodological experience for her Master’s thesis.

3 Questions for Lukas Fu

How can AI support the analysis of biomedical images? This was the question Lukas Fu explored during his school internship at ISAS. The 15-year-old also successfully completed his first programming project.

Lukas Fu, a 15-year-old with short black hair. He is wearing glasses and is sitting on a low wall.

Separating Fluorescence Signals Faster and More Precisely with AI

When different fluorescence signals overlap during microscopy, their clear assignment to specific biological structures becomes difficult. To address this common problem, Dr Davide Panzeri is developing AI-based signal separation methods. The biophysicist has been awarded a Marie Skłodowska-Curie Fellowship by the European Union for his promising research project.

Porträt Dr. Davide Panzeri.

Passionate Research, Shaping the Future

How do GRK5 inhibitors work at the cellular level and within the living organism? Biologist Dr Susanne Grund is working with her colleagues at HI-FIVE on a new therapeutic approach for heart failure. In this portrait, she describes what her day-to-day work looks like, balancing research on human stem cells with studies on mice.

ISAS BFF Uploader

What are you doing at ISAS, Theresa?

Why do mice undergo ultrasound examinations of their hearts? What does a typical working day in the lab involve for a technical assistant in the HI-FIVE research project ? And what challenges does the job present? Theresa Pietz provides fascinating insights into her duties, motivations and experiences working with animals.

Study with Heart: A Doctor Bridging Clinic & Laboratory

What is actually happening behind the scenes of a patient trial? Anna Ruzhyna is a clinical research associate who looks after participants with heart failure as part of the HI-FIVE project. She explains how her work helps to develop new therapeutic approaches for the treatment of heart failure.